Demodex: Another Means of Preventing Contact Lens Dropout? - Report - MDSpire
Advertisement
Demodex: Another Means of Preventing Contact Lens Dropout?
Attendees of the lecture, “Focus on the Lids for OSD Success,” which was provided by Melissa Barnett, OD, learned, in part, about another focus for deterring contact lens dropout: identifying Demodex.
Clinical Report: Demodex and Its Role in Contact Lens Dropout Prevention
Overview
Expand on how identifying and treating Demodex specifically leads to improved lens retention.
Background
Contact lens dropout remains a significant challenge in optometry, affecting both patient satisfaction and practice efficiency. Recent findings suggest that Demodex blepharitis is a common, yet often overlooked, contributor to ocular discomfort in lens wearers. Understanding the role of Demodex in contact lens intolerance is crucial for developing effective management strategies.
Data Highlights
Demodex identified in up to 90% of contact lens wearers; 93% of intolerant wearers had Demodex.
Key Findings
Demodex mites can cause inflammation and degeneration of conjunctival tissue.
They are associated with various ocular conditions including blepharitis and keratitis.
93% of contact lens wearers reporting intolerance had Demodex, while only 6% without symptoms had the mites.
High magnification slit lamp examination is essential for accurate identification of Demodex.
Lotilaner ophthalmic solution is effective in eradicating Demodex.
Clinical Implications
Eye care providers should routinely screen for Demodex in contact lens wearers, particularly those experiencing discomfort. Implementing targeted treatments, such as lotilaner, can enhance patient comfort and reduce dropout rates.
Conclusion
Addressing Demodex infestation is a critical step in managing contact lens intolerance, potentially improving retention and patient satisfaction.
“As optometrists, our responsibility is not only to recognize dry eye disease early but also to match the right treatment to the right patient,” said Dr. Kalfayan.